U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product (Peripheral Stents, PTA Balloons), By Application (Peripheral Arterial Disease, Aneurysms), By End-use, And Segment Forecasts, 2025 - 2030

U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product (Peripheral Stents, PTA Balloons), By Application (Peripheral Arterial Disease, Aneurysms), By End-use, And Segment Forecasts, 2025 - 2030


U.S. Peripheral Vascular Devices And Accessories Market Growth & Trends

The U.S. peripheral vascular devices and accessories market size is expected to reach USD 4.9 billion by 2030, according to a new report by Grand View Research, Inc. The market and is expected to expand at a CAGR of 5.5% from 2025 to 2030. Growing prevalence of venous diseases or Chronic Venous Insufficiency (CVI) is one of the key factors driving the growth of the market. Furthermore, growing geriatric population, and increasing demand for minimally invasive endovascular procedures is further increasing its adoption and bolstering revenue growth over the forecast period.

Based on product type, the peripheral vascular stents segment dominated the market in 2019. Factors contributing to the increase in demand include technological advancements in stent technology and increasing demand for minimally invasive procedures. In addition, the peripheral stent market is majorly driven by a growing patient pool requiring the immediate stent placement, technological innovations in peripheral vascular interventions, and growing number of government initiatives. These factors are further propelling the overall growth.

U.S. Peripheral Vascular Devices And Accessories Market Report Highlights
  • The peripheral stents segment held the largest market share of 20.4% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period
  • In 2024, peripheral arterial disease (PAD) held the largest market share of 45.5%. Peripheral arterial disease dominated the market due to the increasing prevalence of this condition leads to higher demand for interventions
  • The hospital segment dominated the market with a share of 64.2% in 2024. Hospitals dominate the vascular devices and accessories market because they can treat a high volume of patients
  • The ambulatory surgical centers segment is expected to grow significantly during the forecast period. Ambulatory surgical centers (ASCs) have become a key provider in the peripheral vascular devices market, primarily due to the growing trend of outpatient care
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.3. Competitive Insights
Chapter 3. U.S. Peripheral Vascular Devices And Accessories Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of vascular diseases
3.2.1.2. Technological advancements
3.2.1.3. Minimally invasive treatment preference
3.2.2. Market restraint analysis
3.2.2.1. High treatment costs
3.2.2.2. Regulatory and approval challenges
3.3. U.S. Peripheral Vascular Access Devices and Accessories Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
Chapter 4. U.S. Peripheral Vascular Devices And Accessories Market: Product Estimates & Trend Analysis
4.1. U.S. Peripheral Vascular Devices And Accessories Market: Product Dashboard
4.2. U.S. Peripheral Vascular Devices And Accessories Market: Product Movement Analysis
4.3. U.S. Peripheral Vascular Devices And Accessories Market by Product, Revenue
4.4. Peripheral Stents
4.4.1. Peripheral stents market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Iliac artery stents
4.4.2.1. Iliac artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Femoral artery stents
4.4.3.1. Femoral artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.4. Carotid artery stents
4.4.4.1. Carotid artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.5. Renal artery stents
4.4.5.1. Renal artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.6. Others
4.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)
4.5. PTA Balloons
4.5.1. PTA balloons market estimates and forecasts 2018 to 2030 (USD Billion)
4.6. Catheters
4.6.1. Catheters market estimates and forecasts 2018 to 2030 (USD Billion)
4.6.2. Angiography catheters
4.6.2.1. Angiography catheters market estimates and forecasts 2018 to 2030 (USD Billion)
4.6.3. Guiding catheters
4.6.3.1. Guiding catheters market estimates and forecasts 2018 to 2030 (USD Billion)
4.6.4. IVUS/OCT Catheters
4.6.4.1. IVUS/OCT catheters market estimates and forecasts 2018 to 2030 (USD Billion)
4.7. Endovascular Aneurysm Repair Stent Grafts
4.7.1. Endovascular aneurysm repair stent grafts market estimates and forecasts 2018 to 2030 (USD Billion)
4.7.2. Thoracic endovascular aneurysm stent grafts
4.7.2.1. Thoracic endovascular aneurysm stent grafts market estimates and forecasts 2018 to 2030 (USD Billion)
4.7.3. Abdominal endovascular aneurysm stent grafts
4.7.3.1. Abdominal endovascular aneurysm stent grafts market estimates and forecasts 2018 to 2030 (USD Billion)
4.8. Plaque Modification Devices
4.8.1. Plaque modification devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.8.2. Atherectomy devices
4.8.2.1. Atherectomy devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.8.3. Thrombectomy devices
4.8.3.1. Thrombectomy devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.9. Peripheral Accessories
4.9.1. Peripheral accessories market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.2. Guidewires
4.9.2.1. Guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.2.2. Workhorse guidewires
4.9.2.2.1. Workhorse guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.2.3. Specialty guidewires
4.9.2.3.1. Specialty guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.2.4. Extra support guidewires
4.9.2.4.1. Extra support guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.2.5. Frontline finesse guidewires
4.9.2.5.1. Frontline finesse guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.3. Peripheral vascular closure devices
4.9.3.1. Peripheral vascular closure devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.4. Balloon inflation devices
4.9.4.1. Balloon inflation devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.9.5. Introducer sheaths
4.9.5.1. Introducer sheaths market estimates and forecasts 2018 to 2030 (USD Billion)
4.10. Inferior vena cava filters
4.10.1. Inferior vena cava filters market estimates and forecasts 2018 to 2030 (USD Billion)
4.10.2. Permanent filters
4.10.2.1. Permanent filters market estimates and forecasts 2018 to 2030 (USD Billion)
4.10.3. Retrievable filters
4.10.3.1. Retrievable filters market estimates and forecasts 2018 to 2030 (USD Billion)
4.11. Hemodynamic flow alteration devices
4.11.1. Hemodynamic flow alteration devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.11.2. Chronic total occlusion devices
4.11.2.1. Chronic total occlusion devices market estimates and forecasts 2018 to 2030 (USD Billion)
4.11.3. Embolic protection devices
4.11.3.1. Embolic protection devices market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Peripheral Vascular Devices And Accessories Market: Application Estimates & Trend Analysis
5.1. U.S. Peripheral Vascular Devices And Accessories Market: Application Dashboard
5.2. U.S. Peripheral Vascular Devices And Accessories Market: Application Movement Analysis
5.3. U.S. Peripheral Vascular Devices And Accessories Market by Application, Revenue
5.4. Peripheral Arterial Disease (PAD)
5.4.1. Peripheral Arterial Disease (PAD) market estimates and forecasts 2018 to 2030 (USD Billion)
5.5. Aneurysms
5.5.1. Aneurysms market estimates and forecasts 2018 to 2030 (USD Billion)
5.6. Venous Diseases
5.6.1. Venous diseases market estimates and forecasts 2018 to 2030 (USD Billion)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Peripheral Vascular Devices And Accessories Market: End-use Estimates & Trend Analysis
6.1. U.S. Peripheral Vascular Devices And Accessories Market: End Use Dashboard
6.2. U.S. Peripheral Vascular Devices And Accessories Market: End Use Movement Analysis
6.3. U.S. Peripheral Vascular Devices And Accessories Market by End Use, Revenue
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Billion)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company market share analysis, 2024
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Terumo Medical Corporation
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Medtronic
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Boston Scientific Corporation
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Cordis
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Koninklijke Philips N.V.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. AngioDynamics, Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Asahi Intecc Co. Ltd.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. BD
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. BIOTRONIK SE & Co. KG
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Biosensors International Group Ltd.
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. B. Braun SE
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. iVascular
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Merit Medical Systems, Inc.
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
7.4.15. Cook Group Inc
7.4.15.1. Company overview
7.4.15.2. Financial performance
7.4.15.3. Product benchmarking
7.4.15.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings